Ftse Mib
33.746,66
-1,60%
DAX
17.932,17
-1,10%
S&P 500
5.035,69
-1,57%
NASDAQ Composite
15.657,82
-2,04%
Bitcoin
59.973,83
-1,03%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Seagen Inc (SGEN) Seagen Inc (SGEN) Notizie

Seagen Inc

SGEN
228,74
0,00 (0,00%)
30 Apr 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
09/1/202412:12IHMARKETNEWSWall Street Highlights: HPE and Juniper Networks in..
26/12/202312:12EDGAR2Form 15-12G - Securities registration termination [Section..
19/12/202300:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/12/202323:25EDGAR2Form SC 13D/A - General statement of acquisition of..
16/12/202300:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/12/202300:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202323:00PRNUSPADCEV® (enfortumab vedotin-ejfv) with KEYTRUDA®..
14/12/202314:47EDGAR2Form S-8 POS - Securities to be offered to employees in..
14/12/202314:29EDGAR2Form POSASR - Post-effective Amendment to an automatic shelf..
14/12/202314:00EDGAR2Form 8-K - Current report
14/12/202314:00EDGAR2Form 25-NSE - Notification filed by national security..
12/12/202314:32EDGAR2Form 8-K - Current report
12/12/202313:43DJNPfizer to Close $43 Billion Seagen Acquisition This Week
11/12/202301:30BWADCETRIS® (brentuximab vedotin) Plus Novel Immunotherapy..
06/12/202314:15BWTUKYSA® (tucatinib) in Combination with Antibody-Drug..
01/12/202300:04DJNAstellas, Seagen: Cancer Treatment Padcev Supplemental..
30/11/202323:00BWFDA Grants Priority Review for Supplemental Biologics..
14/11/202303:37EDGAR2Form 144/A - Report of proposed sale of securities: [Amend]
14/11/202302:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202301:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/11/202300:37EDGAR2Form 144 - Report of proposed sale of securities
09/11/202322:12EDGAR2Form 144 - Report of proposed sale of securities
03/11/202317:00BWSeagen Highlights First Solid Tumor Data for an ADCETRIS®..
02/11/202318:00BWNew Data for ADCETRIS® (brentuximab vedotin) with..
01/11/202313:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202313:09EDGAR2Form 8-K - Current report
01/11/202313:00BWSeagen Third Quarter 2023 Financial Results Reflect Strong..
22/10/202316:30PRNUSGroundbreaking EV-302 Trial Significantly Extends Overall..
20/10/202313:22IHMARKETNEWSFriday’s Wall Street Highlights: SolarEdge, Intuitive..
19/10/202317:14EDGAR2Form 8-K - Current report
16/10/202314:00BWSeagen to Highlight Overall Survival Data for PADCEV® and..
12/10/202314:00BWSeagen to Report Third Quarter 2023 Financial Results on..
23/9/202301:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202301:48EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202301:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202301:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/9/202301:45EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/9/202313:02DJNMerck, Seagen, Astellas Phase 3 Bladder Cancer Study Hits..
Apertura: Min: Max:
Chiusura: 228,74

La tua Cronologia

NASDAQ
SGEN
Seagen
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network